Bioethics News

Milestone Reached on Path to New Form of Male Contraception

April 13, 2016

(Medical Xpress) – Researchers studying strategies to develop a non-hormonal approach to male contraception have reached an important milestone in their work, discovering a way to produce a key enzyme found only in sperm in sufficient quantities that they can begin designing drugs to stop the sperm from swimming to the egg. The discovery represents a meaningful step toward a birth control drug for men that the researchers hope will be—unlike the pill for women—free of side effects typical of hormonal contraception.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.